Cargando…
Delta-5-desaturase: A novel therapeutic target for cancer management
Delta-5 desaturase (D5D) is a rate-limiting enzyme that introduces double-bonds to the delta-5 position of the n-3 and n-6 polyunsaturated fatty acid chain. Since fatty acid metabolism is a vital factor in cancer development, several recent studies have revealed that D5D activity and expression coul...
Autores principales: | Pang, Lizhi, Shah, Harshit, Xu, Yi, Qian, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390547/ https://www.ncbi.nlm.nih.gov/pubmed/34438249 http://dx.doi.org/10.1016/j.tranon.2021.101207 |
Ejemplares similares
-
Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression
por: Xu, Yi, et al.
Publicado: (2018) -
EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation
por: Pang, Lizhi, et al.
Publicado: (2020) -
Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells
por: Yang, Xiaoyu, et al.
Publicado: (2017) -
Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression
por: Shah, Harshit, et al.
Publicado: (2021) -
Dihomo-γ-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase
por: Xu, Yi, et al.
Publicado: (2018)